Methods for determining a predisposition to develop breast adenocarcinoma or breast inflammatory carcinoma
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 15, 2008
Grant Date -
Feb 24, 2005
app pub date -
Jun 21, 2004
filing date -
Jul 8, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to a method for determining a predisposition to develop cancer in a patient, comprising the step of detecting EN 2 gene or its expression product in said patient or in a biological sample of said patient, whereby detecting presence of at least one of EN 2 gene or its expression product is indicative of a predisposition to develop breast cancer.The present invention also relates to antisense hybridizine to EN2 gene kits for determining predisposition to develop cancer and method of reducing EN2 expression.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully